Patents by Inventor Jurgen Ebbers

Jurgen Ebbers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and computer system for project portfolio management
    Publication number: 20040254959
    Abstract: A computer-implemented method of performing a risk analysis for a project is described. The computer-implemented method includes, generating, in a hierarchical database, a plurality of area checklists in the form of documents, wherein each area checklist has at least one input field into which data is input. Next, the data from the hierarchical database is exported to a relational database. After completion of the exporting step, the relational database is accessed, and the risk analysis is performed on the data that has been exported into the relational database. The risk analysis results of the project are then outputted.
    Type: Application
    Filed: October 20, 2003
    Publication date: December 16, 2004
    Inventors: Karsten Dierksen, Jurgen Ebbers, Reinhard Hirsch, Karsten Malsch, Volker Mues, Edgar Ostinning, Ralf Pakull
  • Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
    Patent number: 5231010
    Abstract: An aprotinin with a deletion of the amino acid proline in position 2 or an addition of alanine-(-2)-glutamine-(-1). Such aprotinin is useful as an active ingredient in medicaments.
    Type: Grant
    Filed: June 25, 1992
    Date of Patent: July 27, 1993
    Assignee: Bayer Aktiengesellschaft
    Inventors: Jurgen Ebbers, Dietrich Horlein, Michael Schedel, Rathindra Das
  • Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
    Patent number: 5164482
    Abstract: An aprotinin with a deletion of the amino acid proline in position 2 or an addition of alanine-(-2)- glutamine-(-1). Such aprotinin is useful as an active ingredient in medicaments.
    Type: Grant
    Filed: August 24, 1990
    Date of Patent: November 17, 1992
    Assignee: Bayer Aktiengesellschaft
    Inventors: Jurgen Ebbers, Dietrich Horlein, Michael Schedel, Rathindra Das